knowledge -WSS

knowledge

author：fashion 2025-10-04 04:01:54 - browse：24

A hand in pink glove holds a blue rack that contains three tubes of blood samples — first opinion coverage from STAT — Joe Raedle/Getty Images

During my 25 years working in clinical trial operations, I’ve seen the biopharmaceutical world talk a big game about making the process easier for the sites running the trials and the patients participating in them. Everyone from trial sponsors to the Food and Drug Administration has been quick to promise simpler processes, less hassle, and better experiences for everyone involved.

But look closer, and you’ll see that these grand promises often fall apart when sponsors implement complicated plans for collecting blood, tissue and other biospecimens and impossible processes for managing those samples. Behind all the talk and regulatory guidance, there’s a reluctance to change how these essential elements of clinical trial execution are handled, putting the very ideals that sponsors are trying to uphold at risk.

The concept of site and patient centricity frequently gets reduced to addressing only superficial gestures, such as committing to promptly paying sites for their work or using tablets for conducting patient surveys. But the essence of centricity extends far beyond these surface-level measures. It lies in addressing the unseen and unmentioned complexities of clinical trials and providing real solutions that focus on truly prioritizing the needs of trial sites and participants.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： Connecting traumatic brain injury and domestic violence

hotspot

entertainment

WSS

Pfizer's Covid pill remains 89% effective in final analysis, company says

The United States is paying nearly triple for new Covid vaccines

Will an HIV vaccine ever be a reality?

What we owe ALS patients — and why one company fell short

Experts study whether long Covid risk adds up with each reinfection

PhRMA sues HHS over Medicare drug price negotiation

focus

knowledge

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

explore

The cancer drug shortage isn’t new — and neither are the solutions

Will an HIV vaccine ever be a reality?

After affirmative action ruling, medical educators look to 'holistic review'

Doctor appointment wait times are getting worse

After affirmative action ruling, medical educators look to 'holistic review'

The biotech scorecard for Q4: 16 stock

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

WHO recommends second malaria vaccine

Medical leaders decry Supreme Court decision on affirmative action

Lawsuit highlights wrinkle for disputes over surprise medical bills

entertainment

Did the public have the right to know Arthur Ashe had AIDS?

PhRMA sues HHS over Medicare drug price negotiation

4 killed, 7 hurt in mass shooting at July 4 block party in Louisiana; no arrests made

Some top drug companies are starting to take action on climate

Community addresses injustice for Long Island mothers

6 solutions to address cancer drug shortages and others

hotspot

hotspot

entertainment

Wikipedia